Related Experiment Video
Updated: Jun 19, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of
Bozena J Katic1,2, Aspasia Katragkou3, Jessica L Alvitres1
1Communicable Disease Service, New Jersey Department of Health, Trenton, New Jersey, USA.
Insights
High SARS-CoV-2 antibody prevalence was found in children. Adult vaccination significantly reduced infection risk in children, highlighting its importance for household COVID-19 prevention strategies.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Public health
Background:
- Household transmission of SARS-CoV-2 is significant, especially in children.
- Understanding pediatric infection prevalence and risk factors is crucial.
Purpose of the Study:
- To determine SARS-CoV-2 antibody prevalence in children.
- To identify risk factors for SARS-CoV-2 antibody positivity in pediatric populations.
Main Methods:
- Oral fluid testing for SARS-CoV-2 antibodies in unvaccinated children (18 months-11 years).
- Caregiver surveys collected demographic, household, and vaccination data.
- Multivariable logistic regression analyzed factors associated with antibody positivity.
Main Results:
- 68% of 870 children tested positive for SARS-CoV-2 antibodies.
- Hispanic and non-Hispanic Black children had higher odds of positivity.
- Children in households with at least one vaccinated adult were 52% less likely to be antibody positive.
Conclusions:
- A high burden of SARS-CoV-2 infection exists among children.
- Adult vaccination is a key protective factor against pediatric COVID-19.
- Community-level adult vaccination can inform household prevention strategies for minors.
Background:
Household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may play a key role in times of increased infection, particularly among children. We aimed to determine the prevalence of SARS-CoV-2 antibodies and identify risk factors associated with SARS-CoV-2 antibody positivity in children.
Methods:
Unvaccinated children aged 18 months to 11 years between August 2022 and June 2023 underwent oral fluid testing for SARS-CoV-2 antibodies. Caregivers completed electronic surveys at 4 major healthcare practices in Northern and Central New Jersey. Information was collected on demographics, household size, vaccination status, and prior SARS-CoV-2-related illness. Multivariable logistic regression determined individual and household-level factors associated with SARS-CoV-2 antibody positivity.
Results:
A total of 870 children provided tests and corresponding surveys. Children were predominantly Hispanic (37%) or non-Hispanic Black (30%), and on average 5.7 years old. Overall SARS-CoV-2 antibody positivity was 68%. Risk factors for SARS-CoV-2 positivity include Hispanic or non-Hispanic Black race/ethnicity (adjusted odds ratios [aOR], 2.29 and 1.95 vs. White race/ethnicity; P < .01) and later enrollment in the study period. Children from households with ≥1 vaccinated adult were 52% less likely to be antibody positive than those from households with no vaccinated adults (aOR: 0.38, [95% confidence interval 0.2 to 0.69]).
Conclusions:
There is high burden of SARS-CoV-2 infection among children over time. Adult vaccination appears to be a protective factor in helping to mitigate coronavirus disease 2019 (COVID-19) infection among children. Increased vaccination of adults in the community can help inform COVID-19 prevention strategies for minors in the household.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Coronavirus
Respiratory Syncytial Virus Disease

